B-Secur
B-Secur, an innovator in advanced biosensing technology, and Galen Data, a leading software platform for medical device-to-cloud connectivity and data analysis, have announced a partnership aimed at providing enhanced cardiac health monitoring capabilities to cardiac device manufacturers. These capabilities include accurate, real-time monitoring, seamless cloud integration, robust data management, and Electronic Health Records integration.
The collaboration combines Galen Data’s industry-leading, secure, compliant medical device cloud platform with B-Secur’s HeartKey Technology, a suite of FDA-cleared ECG algorithms and analytics, enabling medical device companies to significantly reduce their software development timeline, costs, and operational risk.
“Galen Data and B-Secur share a vision of enhancing cardiac care through innovative technology,” said Alex Condon, COO of Galen Data. “By combining our strengths, we are well-positioned to deliver a unique solution that not only meets the demands of cardiac device companies looking to leverage their data quickly and affordably but also showcases an end-to-end solution that truly highlights the potential of cloud-based medical device data platforms. This partnership is a perfect fit, enabling us to provide cardiac device manufacturers with unparalleled insights and capabilities right out of the box.”
B-Secur CCO, Brian Pitstick added: “With the global cardiac monitoring market expected to reach USD 16 billion by 2030*, our partnership with Galen Data represents a timely and exciting leap forward in cardiac care technology solutions, merging clinical grade ECG algorithms with secure cloud connectivity to empower manufacturers and revolutionize patient monitoring. With this unique offering, Galen Data and B-Secur are poised to drive innovation and enhance the capabilities of cardiac health monitoring, providing a comprehensive and reliable platform for the future of cardiac care.”
